Burden of upper gastrointestinal symptoms in patients prescribed dabigatran for stroke prevention

BACKGROUND: Dabigatran, a non-vitamin K antagonist oral anticoagulant, has been shown to prevent stroke in patients with non-valvular atrial fibrillation. Nonetheless, studies show that 10%–30% of those prescribed dabigatran experience dyspepsia that may eventually lead to discontinuation of therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Pak-Hei, Hai, Jo-Jo, Huang, Duo, Ho, Mei-Han, Chan, Esther W, Cheung, Bernard Man-Yung, Chan, Annie On-On, Wong, Ian Chi-Kei, Tse, Hung-Fat, Hung, Ivan Fan-Ngai, Siu, Chung-Wah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976790/
https://www.ncbi.nlm.nih.gov/pubmed/27551422
http://dx.doi.org/10.1177/2050312116662414

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976790/
https://www.ncbi.nlm.nih.gov/pubmed/27551422
http://dx.doi.org/10.1177/2050312116662414

Ejemplares similares